Email Updates

Search form

You are here

AIDS Vaccines

There is momentum and promise in the search for an AIDS vaccine.

An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital AIDS vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

Writing for the South African Mail & Guardian, members of Vaccine Advocacy Resource Group examine the progress the field has made towards an HIV vaccine, detail new HIV vaccine research and remain optimistic for the future.

May 17, 2016
Mail & Guardian

Kathleen MacQueen, Senior Scientist at FHI 360, and Mitchell Warren, Executive Director of AVAC, strongly advocate for the continued investment of resources into HIV vaccine research.

May 18, 2016
Journal of the International AIDS Society
Subscribe to RSS - AIDS Vaccines